Josh Hardman founded Psychedelic Alpha in the spring of 2020. Having studied at the London School of Economics and UC Berkeley, Josh spent several years working in economic policy, advising startups and following the emergence of the so-called ‘psychedelic renaissance’.
Through Psychedelic Alpha, Hardman has authored hundreds of analyses on topics broadly related to psychedelic business, policy and research (e.g., drug development, IP, commercialisation, regulation, and investment). Josh is fortunate to be surrounded and informed by a network of experts and advisors: from lawyers and patent attorneys to neuropsychopharmacologists and investors.